Cargando…
p62/SQSTM1 as an oncotarget mediates cisplatin resistance through activating RIP1‐NF‐κB pathway in human ovarian cancer cells
Platinum‐based therapeutic strategies have been widely used in ovarian cancer treatment. However, drug resistance has greatly limited therapeutic efficacy. Recently, tolerance to cisplatin has been attributed to other factors unrelated to DNA. p62 (also known as SQSTM1) functions as a multifunctiona...
Autores principales: | Yan, Xiao‐Yu, Zhang, Yu, Zhang, Juan‐Juan, Zhang, Li‐Chao, Liu, Ya‐Nan, Wu, Yao, Xue, Ya‐Nan, Lu, Sheng‐Yao, Su, Jing, Sun, Lian‐Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497928/ https://www.ncbi.nlm.nih.gov/pubmed/28498503 http://dx.doi.org/10.1111/cas.13276 |
Ejemplares similares
-
SQSTM1/p62 regulates HTLV-1 tax mediated NF-κB activation
por: Schwob, Aurélien, et al.
Publicado: (2015) -
Clinical significance of SQSTM1/P62 and nuclear factor-κB expression in pancreatic carcinoma
por: Zhang, Zhao-Yang, et al.
Publicado: (2020) -
P62: An emerging oncotarget for osteolytic metastasis
por: Zhang, Jing, et al.
Publicado: (2016) -
The SQSTM1/p62 UBA domain regulates Ajuba localisation, degradation and NF-κB signalling function
por: Sultana, Melanie A., et al.
Publicado: (2021) -
ZZ-dependent regulation of p62/SQSTM1 in autophagy
por: Zhang, Yi, et al.
Publicado: (2018)